Search
Novo Nordisk Pursues Acquisition Opportunities to Bolster Its Obesity Product Range
1 week ago /
Read about 0 minute
Author：小编
On January 13 (local time), Maziar Mike Doustdar, the CEO of Novo Nordisk, announced that the company is actively exploring acquisition opportunities to enhance its obesity product lineup, without setting any constraints on the deal size. He underscored that as long as a potential acquisition aligns with and complements the company's existing assets and presents a favorable cost-benefit ratio, the company is open to pursuing large-scale acquisitions.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
